German biotech company MorphoSys buys US rival for $1.7B The Associated Press Jun 2, 2021 8:00 AM - Germany-based MorphoSys AG says it is buying U.S. rival Constellation...
Germany-based MorphoSys AG says it is buying U.S. rival Constellation Pharmaceuticals Inc. in a deal valuing the biotech company at $1.7 billion
